Europe Endometriosis Market

Europe Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-13308 Publication Date: January-2023 Number of Pages: 88
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Endometriosis Market, by Type
1.4.2 Europe Endometriosis Market, by Treatment
1.4.3 Europe Endometriosis Market, by Distribution Channel
1.4.4 Europe Endometriosis Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Endometriosis Market by Type
3.1 Europe Superficial Peritoneal Lesion Market by Country
3.2 Europe Endometriomas Market by Country
3.3 Europe Others Market by Country

Chapter 4. Europe Endometriosis Market by Treatment
4.1 Europe Oral Contraceptives Market by Country
4.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
4.3 Europe Others Market by Country

Chapter 5. Europe Endometriosis Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country

Chapter 6. Europe Endometriosis Market by Country
6.1 Germany Endometriosis Market
6.1.1 Germany Endometriosis Market by Type
6.1.2 Germany Endometriosis Market by Treatment
6.1.3 Germany Endometriosis Market by Distribution Channel
6.2 UK Endometriosis Market
6.2.1 UK Endometriosis Market by Type
6.2.2 UK Endometriosis Market by Treatment
6.2.3 UK Endometriosis Market by Distribution Channel
6.3 France Endometriosis Market
6.3.1 France Endometriosis Market by Type
6.3.2 France Endometriosis Market by Treatment
6.3.3 France Endometriosis Market by Distribution Channel
6.4 Russia Endometriosis Market
6.4.1 Russia Endometriosis Market by Type
6.4.2 Russia Endometriosis Market by Treatment
6.4.3 Russia Endometriosis Market by Distribution Channel
6.5 Spain Endometriosis Market
6.5.1 Spain Endometriosis Market by Type
6.5.2 Spain Endometriosis Market by Treatment
6.5.3 Spain Endometriosis Market by Distribution Channel
6.6 Italy Endometriosis Market
6.6.1 Italy Endometriosis Market by Type
6.6.2 Italy Endometriosis Market by Treatment
6.6.3 Italy Endometriosis Market by Distribution Channel
6.7 Rest of Europe Endometriosis Market
6.7.1 Rest of Europe Endometriosis Market by Type
6.7.2 Rest of Europe Endometriosis Market by Treatment
6.7.3 Rest of Europe Endometriosis Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sanofi S.A.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 AbbVie, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Trials and Approvals:
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Trials and Approvals:
7.8 Merck & Co., Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 GlaxoSmithKline PLC
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Trials and Approvals:
7.9.5.2 Acquisition and Mergers:
7.10. Consilient Health Limited
7.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo